Advertisement
Nonalbuminuric chronic kidney disease is associated with increased risk of cardiovascular disease and all-cause mortality

Nonalbuminuric CKD Ups Cardiovascular Morbidity in T1DM

0
Also linked to increase in all-cause mortality, but not albuminuria or end-stage renal disease
Intravenous cyclosporine does not improve outcomes versus placebo in patients with anterior ST-segment elevation myocardial infarction who had been referred for primary percutaneous coronary intervention. The findings were published online Aug. 30 in the New England Journal of Medicine to coincide with the annual European Society of Cardiology Congress

Intravenous Cyclosporine Doesn’t Improve STEMI Outcomes

0
For patients undergoing PCI, cyclosporine doesn't prevent adverse left ventricular remodeling at 1 year
For patients who require permanent single-chamber ventricular pacing

Leadless Cardiac Pacemaker Deemed Safe, Effective

0
In most patients, leadless cardiac pacemaker met prespecified pacing and sensing requirements
Azithromycin is routinely prescribed to hospitalized patients despite risk factors for corrected QT prolongation and administration of interacting medications

Azithromycin Routine in Hospital Despite Risk for QTc Prolongation

0
Providers not considering risk of QTc-prolonging meds accumulation, authors say
The outcome of a recent case regarding the termination of physicians by an insurance company following a dispute over the necessity of medical services provided has serious implications for physicians and their patients

AMA: Ruling Makes It Easier for Insurers to Terminate Doctors

0
Court supported insurance company in termination of doctors after dispute over necessity of services
For patients taking dabigatran

Lower Risk of Dabigatran-Tied Bleeding With Gastroprotection

0
Concomitant use of gastroprotective agents linked to lower risk of gastrointestinal bleeding
Repatha (evolocumab) has been approved by the U.S. Food and Drug Administration

FDA Approves Repatha for Certain Patients With High Cholesterol

0
Approved for patients unable to get LDL cholesterol under control with current treatment options
For most atrial fibrillation patients taking warfarin who require temporary interruption for a procedure

Periop Bridging Unnecessary for Most A-Fib Patients on Warfarin

0
Arterial thromboembolism risk doesn't appear to rise without additional drug treatment
Patients with psoriasis are at higher risk of developing arrhythmia

Psoriasis Patients at Higher Risk for Arrhythmia

0
Findings in patients with mild, severe disease and with/without psoriatic arthritis
The nonlinear relationships for low-density lipoprotein and high-density lipoprotein cholesterol with major adverse cardiovascular events seen in rheumatoid arthritis patients do not differ from those in non-rheumatoid arthritis controls

Nonlinear Link for LDL, HDL With MACE Similar in RA, Non-RA

0
Nonlinear relationships seen in RA patients do not differ significantly from non-RA controls